Screening women aged less than 50 years with a family history of breast cancer

European Journal of Cancer

Volumn 34, Issue 6, 1998, Pages 878-883

  Kollias, J ^a   Sibbering, D M ^a   Blarney, R W ^a   Holland, P A M ^a   Obuszko, Z ^a   Wilson, A R M ^a   Evans, A J ^a   Ellis, I O ^a   Elston, C W ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Family history; Screening

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS;

ADOLESCENT; ADULT; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PEDIGREE; PROGNOSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0032078897     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00365-1     Document Type: Article

References (34)

1. Anderson DE. Genetic study of breast cancer: identification of a high risk group. Cancer 1974, 34, 1090-1097.
2. Colditz GA, Willett WC, Hunter DJ, et al. Family history, age, and risk of breast cancer-Prospective data from the Nurses' Health Study. JAMA 1993, 270, 338-343.
3. Claus EB, Risch NJ, Thompson WD. Age of onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990, 131, 961-972.
4. Mettlin C, Croghan I, Natatajan N, Lane W. The association of age and family risk in a case-control study of breast cancer. Am J Epidemiol 1990, 131, 973-983.
5. Nystrom L, Rutqvist LA, Wall S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993,341, 973-978.
6. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer-implications for risk prediction. Cancer 1994, 73, 643-651.
7. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long term follow-up. Histopathology 1991, 19, 403-410.
8. Elis IO, Galea MH, Broughton N, Locker A, Blarney RW, Elston CW. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long term follow-up. Histopathology 1992, 20, 479-489.
9. Galea MH, Blarney RW, Elston CW, Ellis IO. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 1992,22,207-219.
10. Quinn MJ, Babb PJ. Registrations of Cancer Diagnosed in 1991, England and Wales. ONS Population and Health Monitor (19 Sept, 1996). Office for National Statistics, Publication of the Government Statistical Service.
11. Patnick J. NHS Breast Screening Programme-Review 1994. The House of Commons Health Select Committee Report into Breast Cancer Services, 1994.
12. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266, 66-71.
13. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995, 378, 789-792.
14. Savitsky K, Bar-Shira A, Gilat S, et al. A single Ataxia Telengiectasia gene with a product similar to PI-3 kinase. Science 1995,268, 1749-1752.
15. Malkin D, Li FP, Fraumeni JF Jr, et al. Germline p53 mutations in cancer families. Science 1990, 250, 1233-1238.
16. Claus EB, Risch NJ, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990, 131, 961-972.
17. Pickle LW, Johnson KA. Estimating the long term probability of developing breast cancer. J Natl Cancer Inst 1989, 81, 1854-1855.
18. Powles JT, Jones LA, Ashley ES, et al. The Royal Marsden Hospital pilot tamoxifen chemoprevention trial. Breast Cancer Res Treat 1994,31, 73-82.
19. Lynch HT, Watson P. Editorial commentary: Early age at breast cancer onset-a genetic and oncologic perspective. Am J Epidemiol 1990, 131, 984-986.
20. Morrow M. Identification and management of the woman at increased risk for breast cancer development. Breast Cancer Res Treat 1994,31, 53-60.
21. Hoskins KF, Stopfer JE, Calzone KA, et al. Assessment and counselling for women with a family history of breast cancer. JAMA 1995,273, 577-585.
22. Neugut AI, Jacobson JS. The limitations of breast cancer screening for first-degree relatives of breast cancer patients. AmJ Public Health 1995, 86(6), 832-834.
23. Sox HC. Screening mammography in women younger than 50 years of age. Ann Intern Med 1995, 122, 550-552.
24. Burrell HC, Sibbering DM, Wilson ARM, et al. Screening interval breast cancers: Mammographie features and prognostic factors. Radiology 1996, 199, 811-817.
25. Woodman CBJ, Threlfall AG, Boggis CRM, Prior P. Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme in northwest England. BMJ 1995, 310, 224-226.
26. Frisell J, Eklund G, Hellstrom L, Somers A. Analysis of interval breast carcinomas in a randomised screening trial in Stockholm. Breast Cancer Res Treat 1987, 9, 219-225.
27. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontfoft O. Update of the Swedish two-county program of mammographie screening for breast cancer. Radial Clin North Am 1992, 30(1), 187-210.
28. Kerlikowski K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V. Positive predictive value of screening mammography by age and family history of breast cancer. JAMA 1993, 270, 2444-2450.
29. National Health Service Breast Screening Programme. Quality assurance guidelines for surgeons in breast cancer screening. NHSBSP Publication No. 20, 1996.
30. Remvikos Y, Magdelenat H, Dutrillaux B. Genetic evolution of breast cancer III: Age-dependent variations in the correlations between biological indicators of prognosis. Breast Cancer Res Treat 1995,34, 25-33.
31. Tabar L, Fagerberg G, Chen HH, et al. Efficacy of breast cancer screening by age: New results from the Swedish two-counties trial. Cancer 1995, 75, 2507-2517.
32. Frykberg ER, Bland KI. Management of in situ and minimally invasive breast carcinoma. World J Surg 1994, 18, 45-57.
33. Dean L, Geschickter CF. Comedocarcinoma of the breast. Arch Surg 1938, 7, 171-180.
34. Lampejo OT, Barnes DM, Smith P, Millis RR. Evaluation of infiltrating ductal carcinomas with a DCIS component: Correlation of the in-situ component with grade of the infiltrating component. Semin Diag Pathol 1994, 11, 215-222.